incase you haven't seen it (as i hadn't... just saw it now)May 2011 CPS Securities Research Notehttp://www.signaturemetals.com.au/BrokerAnalystReports.htmlor link:May 2011 CPS Securities Research Note
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%